Please find enclosed outcome of the Board Meeting

On June 11, 2025, the Board of Directors of Vivo Bio Tech approved two key appointments. Ms. Priya Rajender Goda (DIN: 07402785) was appointed as Additional Independent Director for a five-year term, subject to shareholder approval via a Special Resolution. Mr. Satyanarayana Vedula (DIN: 09070986), a Chartered Accountant and former Tech Mahindra executive, was appointed as Additional Non-Executive Non-Independent Director for five years, subject to an Ordinary Resolution. The Board also approved seeking shareholder approval through a postal ballot via remote e-voting, and constituted Mr. G. Vinay Babu as the Scrutinizer. Additionally, the Audit Committee, Nomination & Remuneration Committee, and Stakeholders Relationship Committee were reconstituted effective June 12, 2025, with Ms. Priya Rajender Goda taking on the chairperson role for both the Audit Committee and Stakeholders Relationship Committee. Both appointees are confirmed not debarred by SEBI and not disqualified under Section 164 of the Companies Act, 2013.